Skip to content Skip to footer

Reuters Pharma 2025: Post-Conference Talks Featuring Hector De La Riva

Hector De La Riva joins PharmaShots Managing Editor Himanshu Sehgal for a riveting conversation on his recent panel discussion at Reuters Events Pharma 2025. “Reimagine Your 2025 Sales Strategy,” the topic of his panel discussion, examined the ever-evolving commercial landscape and the role of field engagement and customer empowerment in shaping strategic investments.

Hector stresses breaking siloes and agile KPI establishments to achieve enhanced efficiency in commercial excellence.

Hector believes that Integrating technological advances like generative AI models and omnichannel strategies into the biopharma industry can help break siloes and achieve commercial excellence.

Image Source: Canva

About the Author:

Hector De La Riva

Related Post: Reuters Pharma 2025: Pre-Conference Talks Featuring Mike Ryan

Copyright © 2018 – 2026 PharmaShots – All Rights Reserved.

We chose the name PharmaShots to reflect our mission of delivering concise, high-impact, and actionable insights — or “shots” — for decision-makers across the biopharma and healthcare ecosystem. Each story, update, or insight is designed to be sharp, focused, and easy to consume, helping readers quickly grasp what truly matters in a fast-moving industry.

PharmaShots operates at the intersection of media, insights, and brand visibility for the life sciences industry. Our core offerings include:

  • Curated biopharma and healthcare news & analysis

  • Deep-dive insight reports, lists, and industry rankings

  • Sponsored content and brand storytelling

  • Digital marketing and content distribution

  • Event and congress media partnerships

  • Interviews, viewpoints, and expert-led features

  • Newsletter sponsorships and targeted outreach

All services are designed to help companies communicate value, thought leadership, and innovation to the right audience.

PharmaShots content is created and curated by experienced healthcare writers, editors, analysts, and subject-matter contributors with strong backgrounds in biopharma, life sciences, healthcare research, and business insights.

Our editorial process focuses on clarity, accuracy, and relevance, ensuring every piece delivers insight rather than noise.

Our readers come from across the global healthcare and life sciences ecosystem, including:

  • Healthcare decision-makers
  • Biopharma and biotech professionals

  • Medtech and diagnostics leaders

  • Researchers and clinicians

  • Strategy, business development, and competitive intelligence teams

  • Investors and consultants

  • Digital health and AI innovators

  • Marketing, communications, and market access professionals

They rely on PharmaShots to stay informed, make decisions faster, and spot emerging trends early.

PharmaShots is updated daily with fresh content across news, insights, interviews, and special reports. Updates may occur daily or multiple times per week depending on industry activity, major announcements, and ongoing coverage themes.

Readers can stay connected with PharmaShots through multiple channels:

  • Subscribe to our email newsletter for curated weekly updates

  • Follow PharmaShots on LinkedIn and other social platforms

  • Visit the website regularly for new stories and reports

  • Engage with special editions, rankings, and event coverage

These channels ensure you never miss key developments shaping biopharma and healthcare.

You can reach out to PharmaShots through our website’s contact page or via email at connect@pharmashots.com for inquiries, collaborations, or feedback. Visit pharmashots.com for more details

For general inquiries, partnerships, media collaborations, or support, you can reach us at:

Email: connect@pharmashots.com

Address: PharmaShots Media Private Limited

Second Floor, H-65, Sector 63
Noida, Uttar Pradesh, India – 201301

Phone: India: +91 9582 193319 

US/Canada: +1 (289) 778-4900